Xalkori
Xalkori ingredients
| Active ingredient | Strength |
|---|---|
| Crizotinib | 20 mg/1, 50 mg/1, 250 mg/1, 150 mg/1, 200 mg/1 |
What Xalkori is used for
The FDA lists the approved uses on the official label (below). In the EU, crizotinib is approved as Xalkori for:
Xalkori as monotherapy is indicated for: The first line treatment of adults with anaplastic lymphoma kinase (ALK) positive advanced non small cell lung cancer (NSCLC) The treatment of adults with previously treated anaplastic lymphoma kinase (ALK) positive advanced non small cell lung cancer (NSCLC) The treatment of adults with ROS1 positive advanced non small cell lung cancer (NSCLC) The treatment of paediatric patients (age 1 to <18 years) with relapsed or refractory systemic anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) The treatment of paediatric patients (age 1 to <18 years) with recurrent or refractory anaplastic lymphoma kinase (ALK) positive unresectable inflammatory myofibroblastic tumour (IMT)
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Xalkori
- Generic name
- Crizotinib
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Capsule, Capsule, Coated Pellets
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA217581
- On the US market since
- 2011
Official information
- MedlinePlus drug information (search for Crizotinib)
In India
- Crizotinib: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Xalkori?
Xalkori (Crizotinib) is a cancer medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Xalkori?
Xalkori contains Crizotinib (20 mg/1, 50 mg/1, 250 mg/1, 150 mg/1, 200 mg/1).
Is Xalkori approved in Europe?
The same active substance is approved in the EU as Xalkori.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA